CirculationReddy et al.Original Research

Salim Yusuf works in General / Preventive / Lipids affiliated with McMaster University.
Salim Yusuf is Distinguished University Professor of Medicine at McMaster University and Senior Scientist at the Population Health Research Institute in Hamilton, Ontario, Canada. He is a cardiologist and epidemiologist who has led international studies such as INTERHEART and INTERSTROKE. He previously served as Executive Director of the Population Health Research Institute until 2024.
2,196 pubs · 312,126 cites · h-index 259
MBBS
St. John's Medical College, Bangalore University
1976
DPhil
University of Oxford
1980
Distinguished University Professor of Medicine
McMaster University · 1992 - Present
Senior Scientist
Population Health Research Institute · 1992 - Present
Executive Director
Population Health Research Institute · 1999 - 2024
Director of the Division of Cardiology
McMaster University · 1992 - Present
Clinical researcher
National Institutes of Health · 1984 - 1992
CirculationReddy et al.Original Research
JACCKarthikeyan et al.case-control
Low HDL-C prevalence in first AMI supports risk assessment; extends non-Asian lipid associations to South Asians but leaves open therapeutic implications.
JACCMehta et al.RCT
RIVAL tested radial against femoral access in 1,958 patients with STEMI and 5,063 with other acute coronary syndromes. In STEMI, radial access cut death, heart attack, stroke or major non bypass bleeding from 5.2% to 3.1%, and cut deaths from 3.2% to 1.3%. In other acute coronary syndromes, the combined outcome was similar at 3.8% versus 3.5%. Radial access may be preferred in STEMI when the operator has considerable radial experience.
Cardiac Imaging · Hennepin Healthcare Research Institute
Although the reduction in eGFR was numerically higher among the dabigatran arms in the short term, after an average follow-up of 30 months, there was a modest but statistically significant reduction in eGFR in the warfarin group compared with the dabigatran arms.
Journal of the American College of CardiologyBöhm et al.
CirculationJolly et al.Risk Assessment
Cardiologist, University Heart Center Freiburg
Coronary bypass graft failure, however, was not affected
JACCLamy et al.RCT
The COMPASS trial substudy tested rivaroxaban plus aspirin and rivaroxaban alone against aspirin alone in 1,448 patients starting 4 to 14 days after bypass surgery. At one year, graft failure on CT scan was 9.1% on the combination versus 8.0% on aspirin, and 7.8% on rivaroxaban alone versus 8.0% on aspirin. Heart death, stroke or heart attack was also not significantly different across the groups.
JAMA Network OpenSouza et al.Cross-Sectional Study
Cross-sectional study observes higher adiposity and vascular brain injury with ultraprocessed food intake in middle-aged adults, highlighting subclinical cerebrovascular risks.
LancetAnand et al.cross-sectional
South Asian ethnicity was associated with higher CVD prevalence independent of carotid atherosclerosis; leaves open mechanisms involving metabolic and prothrombotic factors.
NEJMYusuf et al.cohort
ACEI may be preferable to ARB in normotensive AMI post-PCI; leaves open confirmation in randomized trials.
LancetAnker et al.cohort
Supports weight-loss monitoring for prognosis in chronic HF; leaves open whether preventing ≥6% loss improves survival.
General / Preventive / Lipids · Population Health Research Institute
INTERSTROKE demonstrates that the majority of stroke is due to common modifiable risk factors. Our findings will inform the development of global population-level interventions to reduce stroke, and how such programmes may be tailored to individual regions, as we did observe some regional differences in the importance of some risk factors by region. This includes better health education, more affordable healthy food, avoidance of tobacco and more affordable medication for hypertension and dyslipidaemia.
The LancetO'Donnell et al.
General / Preventive / Lipids · Population Health Research Institute
While long-term CVD prevention and management strategies have proved successful in reducing the burden in HIC, a change in tack is required to alleviate the disproportionately high impact of CVD in LIC and MIC. Governments in these countries need to start by investing a greater portion of their Gross Domestic Product in preventing and managing non- communicable diseases including CVD, rather than focussing largely on infectious diseases.
The LancetYusuf et al.
LancetMagnussen et al.Original Research
Meyre et al.cohort
Supports epigenetic prognostication in HF; leaves open whether scores add value beyond standard models.
Journal of the Endocrine SocietyAl‐Khazraji et al.cross-sectional
Waist circumference is a practical and robust surrogate for MRI-measured visceral and hepatic fat, potentially improving cardiometabolic risk stratification compared to BMI alone.
Blood Pressure and Hypertension Studies · Ollscoil na Gaillimhe – University of Galway
Stroke prevention is a priority for physicians, and despite advances it remains difficult to predict when a stroke will occur. Many studies have focused on medium to long-term exposures, such as hypertension, obesity or smoking. Our study aimed to look at acute exposures that may act as triggers.
European Heart JournalSmyth et al.
JACCOlsson et al.cohort
Atrial fibrillation is a significant predictor of adverse cardiovascular outcomes in heart failure regardless of ejection fraction, with a higher relative risk increase in those with preserved ejection fraction.
Cross-Cutting Cardiology · Sigmund Freud Privatuniversität Wien
The results of our analyses, and those previously published, regarding the use of low-dose rivaroxaban added to aspirin are clear and compelling. The time to begin implementing this treatment is now.
European Heart JournalHori et al.
Gallbladder and Bile Duct Disorders · Christian Medical College, Vellore
After examining the progress of medication use for secondary cardiovascular (CVD) prevention, our research indicates that there continues to be substantial under-utilization of these medications with little improvement over time, and that global targets are unlikely to be reached.
Journal of the American College of CardiologyJoseph et al.
LancetHijazi et al.cohort
The biomarker-based ABC-bleeding score outperforms conventional HAS-BLED and ORBIT scores for predicting major bleeding in patients with atrial fibrillation on oral anticoagulation.